Olema Pharmaceuticals (OLMA) Accumulated Depreciation (2020 - 2023)
Olema Pharmaceuticals (OLMA) posted quarterly Accumulated Depreciation of $698000.0 for Q3 2023, up 44.21% year-over-year from $484000.0 in Q3 2022, and down 6.18% quarter-over-quarter from $744000.0 in Q2 2023.
Olema Pharmaceuticals (OLMA) Accumulated Depreciation (2020 - 2023) Analysis & Trends
Olema Pharmaceuticals (OLMA) has reported Accumulated Depreciation for 4 consecutive years, with $698000.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Accumulated Depreciation rose 44.21% year-over-year to $698000.0; the TTM figure through Sep 2023 stood at $698000.0 (up 44.21% YoY), while the FY2022 annual figure was $581000.0, up 159.38% from the prior year.
- Accumulated Depreciation declined to $698000.0 in Q3 2023 per OLMA's latest filing, from $744000.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $744000.0 in Q2 2023 and bottomed at $62000.0 in Q4 2020.
- Historically, Accumulated Depreciation has averaged $374833.3 across 4 years, with a median of $350500.0 in 2022.
- Annual changes were most pronounced in 2022 — Accumulated Depreciation jumped 340.0% — and 2023, when it surged 44.21%.
- Olema Pharmaceuticals' Accumulated Depreciation stood at $62000.0 in 2020, then soared by 261.29% to $224000.0 in 2021, then soared by 159.38% to $581000.0 in 2022, then climbed by 20.14% to $698000.0 in 2023.
- Business Quant data shows OLMA's Accumulated Depreciation at $698000.0 in Q3 2023, $744000.0 in Q2 2023, and $681000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Olema Pharmaceuticals | 930.10 Mn | 930.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 698,000.00 |
| Jun 30, 2023 | 744,000.00 |
| Mar 31, 2023 | 681,000.00 |
| Dec 31, 2022 | 581,000.00 |
| Sep 30, 2022 | 484,000.00 |
| Jun 30, 2022 | 393,000.00 |
| Mar 31, 2022 | 308,000.00 |
| Dec 31, 2021 | 224,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Jun 30, 2021 | 102,000.00 |
| Mar 31, 2021 | 70,000.00 |
| Dec 31, 2020 | 62,000.00 |